Boston Medical Center
Hours: 8:00AM - 5:00PM
Clinical Director, Center for Cancer and Blood Disorders
Eggleton, P., B. Ghebrihiwet, K. Sastry, J. Coburn, K.S. Zaner, K.B.M. Reid and A.I. Tauber. Identification of a gC1q Binding Protein (gC1q-R) on the Surface of Human Neutrophils: Subcellular Localization and Binding Properties in Comparison with cC1q-R. J. Clinical Investigation. 1995; 95:1569-1578.
Hartshorn, K.L., M. White, D. Voelker, J. Coburn, K. Zaner and E. Crouch. Mechanism of Binding of Surfactant Protein D. to Influenza A Viruses: importance of binding to haemagglutinin to Antiviral Activity. Biochem. J. 2000; 351 Pt 2:449-58, 2000 Oct 15.
Akerley, W., R. Lee, K. Zaner, N. Ready, T. Mega, H. Safran and T. Kennedy. Phase II Trial of Weekly Paclitaxel and Gemcitabine for Previously Untreated Stage IIIB-IV Non-Small-Cell Lung Cancer. Cancer 2006;107:1050-4.
Dragovich, T., S. McCoy, S. Urba, K. Zaner, A. Baker, Jiang Wang, Karen Winstead, Chris Hackett, John Bishop, C. Fenoglio-Preiser, C. Fenoglio-Preiser, C. Blanke, J. Abbruzzese. SWOG 0127: Phase II Trial of Erlotinib in Gastroesophageal Junction GEJ and Gastric Adenocarcinomas. Journal of Clinical Oncology 2006;24:4922-4927.